FedInvent Patent Applications

New Taxpayer Funded Patent Applications for Thursday, June 03, 2021 

This page was updated on Saturday, July 17, 2021 at 01:39 AM GMT

FedInvent analyzed 169 taxpayer funded patent applications this week.

On Thursday, June 03, 2021, the United States Patent and Trademark Office (USPTO) published  169 patent applications; including 160 applications containing government interest statements and 22 applications where federal government agencies were an assignee or applicant on the patent application. Together, 169 patent applications published this week are the result of U.S. Government funded research & development.

Learn More About Taxpayer Funded Patents Here

The List of This Week's Patent Applications

Just a list — patent application publication number with a link and the title, for those patentistas who like to browse.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.
Patent Application Title
001 20210161084
 
DISPOSABLE DIAPER RECYCLING AND APPLICATIONS THEREOF 
002 20210161126
 
Devices and Methods to Improve and Assess Viability of Human Livers 
003 20210161150
 
METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM 
004 20210161383
 
CHROMATIC BIOLUMINESCENCE AS A CELLULAR LEVEL READOUT SYSTEM OF NEURAL ACTIVITY 
005 20210161385
 
LINE EXCITATION ARRAY DETECTION MICROSCOPY 
006 20210161388
 
METHOD, SYSTEM AND SPECULUM-FREE OPTICAL PROBE FOR OPTICAL ASSESSMENT OF CERVIX, AND APPLICATIONS OF SAME 
007 20210161395
 
NON-INVASIVE VENOUS WAVEFORM ANALYSIS FOR EVALUATING A SUBJECT 
008 20210161405
 
VITAL SIGNS MONITOR 
009 20210161467
 
METHOD OF MONITORING RESPIRATORY RATE IN A HEALTH MONITORING DEVICE 
010 20210161507
 
SYSTEM AND METHOD FOR INTEGRATED BIOPSY AND THERAPY 
011 20210161825
 
CHLOROQUINE-BASED MATERIALS FOR THE TREATMENT OF DISEASES 
012 20210161836
 
TREATMENT OF DEMYELINATING DISORDERS 
013 20210161837
 
METHODS FOR TREATING CANCER WITH RORGAMMA INHIBITORS 
014 20210161845
 
METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS 
015 20210161848
 
METHODS AND COMPOSITIONS RELATING TO LIPOKINES FOR TREATING METABOLIC DISORDERS 
016 20210161850
 
USE OF KETONE ESTERS FOR PREVENTION OF CNS OXYGEN TOXICITY 
017 20210161861
 
USE OF METHADONE METABOLITES FOR TREATMENT OF ANXIETY AND DEPRESSION 
018 20210161868
 
ANTI-INFLAMMATORY THERAPY IN ARRHYTHMOGENIC CARDIOMYOPATHY (ACM) 
019 20210161881
 
METHODS OF INHIBITING FORMATION OF ALPHA SYNUCLEIN AGGREGATES 
020 20210161890
 
COMPOSITIONS AND METHODS FOR TREATING BRAIN DYSFUNCTION 
021 20210161891
 
TREATMENT OF POLYCYSTIC DISEASES WITH AN HDAC6 INHIBITOR 
022 20210161900
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF SENESCENT TUMOR CELLS 
023 20210161910
 
Combining BACE1 Inhibitors With mGluR Agonists For Alzheimer\'s Disease Therapy 
024 20210161913
 
OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER 
025 20210161928
 
CANCER THERAPY VIA A COMBINATION OF EPIGENETIC MODULATION AND IMMUNE MODULATION 
026 20210161937
 
ACTIVATION OF MITOCHONDRIAL UNCOUPLING AS A THERAPEUTIC INTERVENTION 
027 20210161943
 
PAK4 INHIBITORS AND METHODS OF USE 
028 20210161958
 
COMPOSITIONS AND METHODS FOR TREATING MELANOMA WITH A CHIMERIC ANTIGEN RECEPTOR 
029 20210161965
 
KIR3DL1/HLA-B SUBTYPES FOR HEMATOPOIETIC CELL TRANSPLANTATION DONOR SELECTION 
030 20210161966
 
METHODS OF TREATING LYSOSOMAL DISORDERS 
031 20210161974
 
MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT 
032 20210161979
 
CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER 
033 20210161980
 
SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT 
034 20210161999
 
COMPOSITIONS AND METHODS RELATED TO OVERCOMING INNATE IMMUNE BARRIERS TO CANCER IMMUNOTHERAPY 
035 20210162002
 
REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS 
036 20210162007
 
MODULATING NUCLEAR RECEPTORS AND METHODS OF USING SAME 
037 20210162009
 
CHEMOKINE VARIANTS AS IMMUNE STIMULANTS 
038 20210162011
 
Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes 
039 20210162014
 
ENCAPSULATION OF ULTRA-STABLE INSULIN ANALOGUES WITH POLYMER MELTS 
040 20210162020
 
SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) 
041 20210162038
 
PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS 
042 20210162039
 
MULTIEPITOPE FUSION ANTIGENS FOR VACCINATION AND METHODS OF MAKING AND USING SUCH ANTIGENS 
043 20210162048
 
Photoswitchable HDAC Inhibitors 
044 20210162050
 
TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT 
045 20210162053
 
NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS 
046 20210162056
 
TARGETING MACULA DENSA CELLS AS A NEW THERAPEUTIC APPROACH FOR KIDNEY DISEASE 
047 20210162065
 
MULTI-FUNCTIONAL CANCER DRUG DELIVERY NANODEVICE FOR PRECISION MEDICINE 
048 20210162066
 
RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF 
049 20210162076
 
Aptamer Compositions and Methods of Use Thereof 
050 20210162127
 
ADAPTIVE ZONE MODEL PREDICTIVE CONTROL WITH A GLUCOSE AND VELOCITY DEPENDENT DYNAMIC COST FUNCTION FOR AN ARTIFICIAL PANCREAS 
051 20210162371
 
FUNCTIONALIZED POROUS ORGANIC POLYMERS AS URANIUM NANO-TRAPS FOR EFFICIENT URANIUM EXTRACTION 
052 20210162373
 
Zinc(II) and Gallium(III) Catalysts for Olefin Reactions 
053 20210162408
 
Expandable Arrays and Methods of Use 
054 20210162504
 
THREE-DIMENSIONAL LASER-ASSISTED PRINTING OF STRUCTURES FROM NANOPARTICLES 
055 20210162709
 
ORGANICALLY MODIFIED CHALCOGENIDE POLYMERS FOR USE AS OPTICAL ADHESIVE MATERIALS 
056 20210163155
 
SATELLITE DEPLOYER DOOR RELEASE MECHANISM 
057 20210163297
 
DENDRITIC MATERIALS WITH HIERARCHICAL POROSITY 
058 20210163298
 
NANODIAMOND REDUCTION PHOTOCHEMISTRY 
059 20210163370
 
DOPED MATERIALS/ALLOYS AND HOT ISOSTATIC PRESSING METHOD OF MAKING SAME 
060 20210163377
 
CATALYTIC SYNTHESIS OF SUPER LINEAR ALKENYL ARENES USING RHODIUM CATALYSTS 
061 20210163384
 
Compositions and Methods for Reducing Enones to Saturated Alcohols 
062 20210163386
 
METHODS AND COMPOSITIONS FOR THE CATALYTIC UPGRADING OF ALCOHOLS 
063 20210163393
 
HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF 
064 20210163403
 
COMPOSITIONS AND METHODS FOR TREATING CANCER 
065 20210163406
 
Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs 
066 20210163424
 
ECO-FRIENDLY MATERIALS AND METHODS FOR RENEWABLE AND SUSTAINABLE APPLICATIONS IN MATERIAL CHEMISTRY 
067 20210163453
 
DERIVATIVES OF PAPAVERINE THAT ARE EFFECTIVE HYPOXIC TUMOR RADIOSENSITIZERS 
068 20210163454
 
SMALL MOLECULE INHIBITORS OF EBOLA AND LASSA FEVER VIRUSES AND METHODS OF USE 
069 20210163506
 
BORON-CONTAINING COMPOUNDS 
070 20210163508
 
HIGHLY EFFICIENT FREE RADICAL PHOTOPOLYMERIZATIONS THROUGH ENABLED DARK CURE 
071 20210163521
 
AMPHIPHILIC AMINOGLYCOSIDE CONNEXIN HEMICHANNEL INHIBITORS 
072 20210163532
 
NOVEL MACROCYCLIC OPIOID PEPTIDES 
073 20210163533
 
CELL PENETRATING PEPTIDE 
074 20210163539
 
Wet Adhesive Peptides 
075 20210163542
 
VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE 
076 20210163543
 
SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE 
077 20210163551
 
DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS 
078 20210163555
 
TARGETING P18 FOR mTOR-RELATED DISORDERS 
079 20210163556
 
BDNF MIMETIC PEPTIDE AMPHIPHILES 
080 20210163557
 
METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER\'S DISEASE AND IMPROVING NORMAL MEMORY 
081 20210163558
 
FIBROUS PROTEINACEOUS NETWORKS AND METHODS OF USE THEREOF 
082 20210163570
 
ENGINEERED CELLS, T CELL IMMUNE MODULATING ANTIBODIES AND METHODS FOR USING THE SAME 
083 20210163578
 
HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY 
084 20210163602
 
PSGL-1 MODULATORS AND USES THEREOF 
085 20210163609
 
METHOD FOR TREATING AUTOIMMUNE DISEASE 
086 20210163624
 
T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR A WTI PEPTIDE PRESENTED BY HLA-A2 
087 20210163676
 
OLEFIN METATHESIS PHOTOPOLYMERS 
088 20210163707
 
POLYELEMENTAL HETEROSTRUCTURE NANOPARTICLES AND METHODS OF MAKING THE SAME 
089 20210163731
 
TRANSIENT POLYMER FORMULATIONS, ARTICLES THEREOF, AND METHODS OF MAKING AND USING SAME 
090 20210163759
 
Infrared Fluorescent Coatings 
091 20210163766
 
CHALCOGENIDE GLASS BASED INKS OBTAINED BY DISSOLUTION OR NANOPARTICLES MILLING 
092 20210163770
 
THIN FILMS PRINTED WITH CHALCOGENIDE GLASS INKS 
093 20210163776
 
COATING COMPOSITIONS, PROCESSES, AND APPLICATIONS FOR LOW FRICTION AND HIGH DURABILITY SUBSTRATES 
094 20210163797
 
BODY FLUID RESISTANT TISSUE ADHESIVES 
095 20210163867
 
PERFUSION BIOREACTOR DRIVEN BY OSMOTIC PRESSURE GRADIENTS 
096 20210163869
 
PRESSURE-DRIVEN, ADJUSTABLE THROUGHPUT FLUIDICS FOR TISSUE AND CELL PERIFUSIONS 
097 20210163872
 
Cell Reprogramming Therapy 
098 20210163888
 
INDUCTION OF MYELINATING OLIGODENDROCYTES IN HUMAN CORTICAL SPHEROIDS 
099 20210163892
 
GENERATING HPV ANTIGEN-SPECIFIC CELLS FROM A NAIVE T CELL POPULATION 
100 20210163900
 
NUCLEIC ACID MODIFICATION WITH TOOLS FROM OXYTRICHA 
101 20210163914
 
FUSION TAG FOR INCREASING WATER SOLUBILITY AND EXPRESSION LEVEL OF TARGET PROTEIN AND USES THEREOF 
102 20210163917
 
ENZYME FORMULATION AND METHOD FOR DEGRADATION 
103 20210163924
 
EVOLUTION OF BONT PEPTIDASES 
104 20210163938
 
MRNA Driven Expression of RNA Editors for Treatment of Pathologies 
105 20210163940
 
COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES 
106 20210163944
 
NOVEL CAS12B ENZYMES AND SYSTEMS 
107 20210163947
 
ULTRASENSITIVE AND MULTIPLEXED CELL-FREE BIOSENSORS USING CASCADED AMPLIFICATION AND POSITIVE FEEDBACK 
108 20210163948
 
RNA TARGETING OF MUTATIONS VIA SUPPESSOR tRNAs AND DEAMINASES 
109 20210163949
 
MODULATION OF ALTERNATIVE MDM2 SPLICING 
110 20210163954
 
METHODS OF TREATING VEGF/VEGFR RESISTANT PROSTATE CANCER USING COMBINATION THERAPY 
111 20210163964
 
ENGINEERED STREPTOMYCES ALBUS STRAINS 
112 20210163966
 
PRODUCTION OF ORGANIC ACIDS FROM ASPERGILLUS CIS-ACONITIC ACID DECARBOXYLASE (CADA) DELETION STRAINS 
113 20210163969
 
COMBINED TRANSCRIPTION AND TRANSLATION PLATFORM DERIVED FROM PLANT PLASTIDS AND METHODS FOR IN VITRO PROTEIN SYNTHESIS AND PROTOTYPING OF GENETIC EXPRESSION IN PLANTS 
114 20210163978
 
IMMUNE RECEPTOR CONFERRING BROAD SPECTRUM FUNGAL RESISTANCE IN SORGHUM 
115 20210163984
 
COMPOSITIONS FOR REDUCING SARCOLIPIN EXPRESSION AND PREVENTING AND TREATING MUSCULAR DYSTROPHY AND CARDIOMYOPATHY AND METHODS OF USE 
116 20210163988
 
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON 
117 20210163993
 
COMPOSITIONS AND METHODS FOR PRODUCTION OF PROTEINS 
118 20210164005
 
METHODS FOR INDUCING BIOORTHOGONAL REACTIVITY 
119 20210164011
 
BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME 
120 20210164026
 
STOICHIOMETRIC TUNING OF NUCLEIC ACID HYBRIDIZATION PROBES BY AUXILIARY OLIGONUCLEOTIDE SPECIES 
121 20210164054
 
BIOMARKERS FOR CANCER IMMUNOTHERAPY OUTCOMES 
122 20210164056
 
USE OF METASTASES-SPECIFIC SIGNATURES FOR TREATMENT OF CANCER 
123 20210164059
 
ON DEMAND, PORTABLE, CELL-FREE MOLECULAR SENSING PLATFORM 
124 20210164116
 
REACTOR WITH ADVANCED ARCHITECTURE FOR THE ELECTROCHEMICAL REACTION OF CO2, CO AND OTHER CHEMICAL COMPOUNDS 
125 20210164118
 
NOVEL MULTI-METAL CATALYSTS AND DEVICES AND METHODS OF USE THEREOF 
126 20210164503
 
Method and Apparatus of Plasma Flow Control for Drag Reduction 
127 20210164592
 
CONDUITS FOR TRANSPORTING FLUIDS AND METHODS OF FABRICATING THE SAME 
128 20210164695
 
FALLING PARTICLE RECEIVER SYSTEMS WITH MASS FLOW CONTROL 
129 20210164697
 
Multi-Stage Falling Particle Receivers 
130 20210164841
 
Systems and Methods for High-Speed, Spectroscopic, Gas-Phase Thermometry 
131 20210164870
 
MICROFLUIDIC DEVICES FOR INVESTIGATING CRYSTALLIZATION 
132 20210164923
 
METHODS OF PREPARING SINGLE-WALLED CARBON NANOTUBE NETWORKS 
133 20210164930
 
METAL-ORGANIC FRAMEWORKS AS ION-TO-ELECTRON TRANSDUCERS AND DETECTORS 
134 20210164953
 
METHOD AND APPARATUS FOR ANALYZING STALK STRENGTH 
135 20210164955
 
MEASURING CONCENTRATION OF ANALYTES IN LIQUID SAMPLES USING SURFACE-ENHANCED RAMAN SPECTROSCOPY 
136 20210164971
 
DROPLET ARRAYS FOR DETECTION AND QUANTIFICATION OF ANALYTES 
137 20210164991
 
INDUCED COMMON ANTIBODY RESPONSE 
138 20210164992
 
COMPOSITIONS AND METHODS RELATED TO INNATE RESPONSE TO DNA AND REGULATION OF INTERFERON-BETA 
139 20210164998
 
DISCRIMINATING PARKINSON\'S DISEASE FROM MULTIPLE SYSTEM ATROPHY USING ALPHA-SYNUCLEIN PMCA 
140 20210165065
 
Methods for Correcting Motion-Encoding Gradient Nonlinearities in Magnetic Resonance Elastography 
141 20210165069
 
ULTRASONIC BEACON TRACKING 
142 20210165092
 
SYSTEM FOR SENSING BACKSCATTER TAG COMMUNICATIONS FROM RETRODIRECTIVE ANTENNA ARRAYS 
143 20210165381
 
SYSTEM ARCHITECTURE AND METHOD OF PROCESSING DATA THEREIN 
144 20210165417
 
COOPERATIVE GUIDANCE SYSTEM AND METHOD 
145 20210165606
 
APPARATUS AND METHODS FOR MANAGING PACKET TRANSFER ACROSS A MEMORY FABRIC PHYSICAL LAYER INTERFACE 
146 20210165772
 
DISCOVERING AND MERGING ENTITY RECORD FRAGMENTS OF A SAME ENTITY ACROSS MULTIPLE ENTITY STORES FOR IMPROVED NAMED ENTITY DISAMBIGUATION 
147 20210165852
 
COMPUTER-IMPLEMENTED PERCEPTUAL APPARATUS 
148 20210165984
 
Polarization-based coding/encryption using organic charge-transfer materials 
149 20210166078
 
LEVERAGING SMART-PHONE CAMERAS AND IMAGE PROCESSING TECHNIQUES TO CLASSIFY MOSQUITO GENUS AND SPECIES 
150 20210166107
 
EVENT-BASED NEURAL NETWORK WITH HIERARCHICAL ADDRESSING FOR ROUTING EVENT PACKETS BETWEEN CORE CIRCUITS OF THE NEURAL NETWORK 
151 20210166138
 
SYSTEMS AND METHODS FOR AUTOMATICALLY DETECTING AND REPAIRING SLOT ERRORS IN MACHINE LEARNING TRAINING DATA FOR A MACHINE LEARNING-BASED DIALOGUE SYSTEM 
152 20210166159
 
METHODS OF CHEMICAL COMPUTATION 
153 20210166393
 
Pixel-wise Hand Segmentation of Multi-modal Hand Activity Video Dataset 
154 20210166433
 
DOMAIN MATCHING METHODS FOR TRANSPORTABLE IMAGING APPLICATIONS 
155 20210166583
 
SYSTEM AND METHOD FOR THREE-DIMENSIONAL AUGMENTED REALITY GUIDANCE FOR USE OF EQUIPMENT 
156 20210166782
 
CLINICAL INTERPRETATION OF GENOMIC AND TRANSCRIPTOMIC DATA AT THE POINT OF CARE FOR PRECISION CANCER MEDICINE 
157 20210166783
 
METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS 
158 20210166927
 
SAMPLE QUANTITATION USING A MINIATURE MASS SPECTROMETER 
159 20210167244
 
METHODS OF FABRICATING PLANAR INFRARED PHOTODETECTORS 
160 20210167390
 
DRY MILLING ADDITIVE AND PROCESS 
161 20210167394
 
PROTECTIVE LAYERS FOR BATTERY ELECTRODES 
162 20210167395
 
POROUS METAL-ION AFFINITY MATERIAL 
163 20210167427
 
METHOD AND SYSTEM TO SEPARATE OPTICALLY MEASURED COUPLED PARAMETERS 
164 20210167429
 
PHOTO-ASSISTED FAST CHARGING OF LITHIUM MANGANESE OXIDE SPINEL (LiMn2O4) IN LITHIUM-ION BATTERIES 
165 20210167462
 
Sodium Electrochemical Interfaces with NaSICON-Type Ceramics 
166 20210167494
 
PROGRAMMABLE BEAMFORMING SYSTEM INCLUDING ELEMENT-LEVEL ANALOG CHANNELIZER 
167 20210167743
 
FAST AMPLITUDE DETECTOR AND AUTOMATIC GAIN CONTROL 
168 20210168063
 
Distributed, Packet-Mediated, Packet Routing 
169 20210168238
 
Methods and Systems for Detecting Disinformation and Blocking Robotic Calls 

Up to Start Of Table

Patent Applications Count By Department

The count of taxpayer-funded patents granted by the United States Patent and Trademark Office (USPTO) this week that contain a Government Interest Statement in the body of the patent documents or where the government is an assignee. Agency numbers are aggregated by the agency named in the Government Interests Statement and the contract number cited in the patent.

Department This Week
Department of Health and Human Services (HHS) 88
National Science Foundation (NSF) 34
Department of Defense (DOD) 33
Department of Energy (DOE) 19
Small Business Administration (SBA) 7
Department of Agriculture (USDA) 2
Department of Veterans Affairs (DVA) 2
National Aeronautics and Space Administration (NASA) 2
Central Intelligence Agency (CIA) 1
Department of Commerce (DOC) 1
Department of Homeland Security (DHS) 1
Department of Transportation (USDOT) 1
U.S. Agency for International Development (USAID) 1
Government Rights Acknowledged 4

Patent Applications by Funding Agency

FedInvent Patents reflects patents with Government Interests Statements in the body of the patent as required by the Bayh-Dole Act indicating the holder of a federal contract, grant, or cooperative agreement has elected to retain the title of inventions conceived and reduced to practice during that contract; and patents where an agency of the US Federal government has elected to retain the title to the patent.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.

Click the Panel to See The Patent Application for Each Agency

Take Me To The Details
Patent Title
001 20210161126
 
Devices and Methods to Improve and Assess Viability of Human Livers 
002 20210161150
 
METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM 
003 20210161383
 
CHROMATIC BIOLUMINESCENCE AS A CELLULAR LEVEL READOUT SYSTEM OF NEURAL ACTIVITY 
004 20210161385
 
LINE EXCITATION ARRAY DETECTION MICROSCOPY 
005 20210161467
 
METHOD OF MONITORING RESPIRATORY RATE IN A HEALTH MONITORING DEVICE 
006 20210161507
 
SYSTEM AND METHOD FOR INTEGRATED BIOPSY AND THERAPY 
007 20210161825
 
CHLOROQUINE-BASED MATERIALS FOR THE TREATMENT OF DISEASES 
008 20210161836
 
TREATMENT OF DEMYELINATING DISORDERS 
009 20210161837
 
METHODS FOR TREATING CANCER WITH RORGAMMA INHIBITORS 
010 20210161845
 
METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS 
011 20210161848
 
METHODS AND COMPOSITIONS RELATING TO LIPOKINES FOR TREATING METABOLIC DISORDERS 
012 20210161861
 
USE OF METHADONE METABOLITES FOR TREATMENT OF ANXIETY AND DEPRESSION 
013 20210161868
 
ANTI-INFLAMMATORY THERAPY IN ARRHYTHMOGENIC CARDIOMYOPATHY (ACM) 
014 20210161881
 
METHODS OF INHIBITING FORMATION OF ALPHA SYNUCLEIN AGGREGATES 
015 20210161891
 
TREATMENT OF POLYCYSTIC DISEASES WITH AN HDAC6 INHIBITOR 
016 20210161900
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF SENESCENT TUMOR CELLS 
017 20210161910
 
Combining BACE1 Inhibitors With mGluR Agonists For Alzheimer\'s Disease Therapy 
018 20210161928
 
CANCER THERAPY VIA A COMBINATION OF EPIGENETIC MODULATION AND IMMUNE MODULATION 
019 20210161937
 
ACTIVATION OF MITOCHONDRIAL UNCOUPLING AS A THERAPEUTIC INTERVENTION 
020 20210161943
 
PAK4 INHIBITORS AND METHODS OF USE 
021 20210161958
 
COMPOSITIONS AND METHODS FOR TREATING MELANOMA WITH A CHIMERIC ANTIGEN RECEPTOR 
022 20210161965
 
KIR3DL1/HLA-B SUBTYPES FOR HEMATOPOIETIC CELL TRANSPLANTATION DONOR SELECTION 
023 20210161966
 
METHODS OF TREATING LYSOSOMAL DISORDERS 
024 20210161974
 
MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT 
025 20210161979
 
CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER 
026 20210161980
 
SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT 
027 20210161999
 
COMPOSITIONS AND METHODS RELATED TO OVERCOMING INNATE IMMUNE BARRIERS TO CANCER IMMUNOTHERAPY 
028 20210162007
 
MODULATING NUCLEAR RECEPTORS AND METHODS OF USING SAME 
029 20210162009
 
CHEMOKINE VARIANTS AS IMMUNE STIMULANTS 
030 20210162011
 
Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes 
031 20210162014
 
ENCAPSULATION OF ULTRA-STABLE INSULIN ANALOGUES WITH POLYMER MELTS 
032 20210162020
 
SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) 
033 20210162038
 
PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS 
034 20210162048
 
Photoswitchable HDAC Inhibitors 
035 20210162050
 
TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT 
036 20210162053
 
NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS 
037 20210162056
 
TARGETING MACULA DENSA CELLS AS A NEW THERAPEUTIC APPROACH FOR KIDNEY DISEASE 
038 20210162065
 
MULTI-FUNCTIONAL CANCER DRUG DELIVERY NANODEVICE FOR PRECISION MEDICINE 
039 20210162066
 
RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF 
040 20210162127
 
ADAPTIVE ZONE MODEL PREDICTIVE CONTROL WITH A GLUCOSE AND VELOCITY DEPENDENT DYNAMIC COST FUNCTION FOR AN ARTIFICIAL PANCREAS 
041 20210162408
 
Expandable Arrays and Methods of Use 
042 20210163384
 
Compositions and Methods for Reducing Enones to Saturated Alcohols 
043 20210163393
 
HINOKITIOL ANALOGUES, METHODS OF PREPARING AND PHARMACEUTICAL COMPOSITIONS THEREOF 
044 20210163403
 
COMPOSITIONS AND METHODS FOR TREATING CANCER 
045 20210163406
 
Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs 
046 20210163453
 
DERIVATIVES OF PAPAVERINE THAT ARE EFFECTIVE HYPOXIC TUMOR RADIOSENSITIZERS 
047 20210163454
 
SMALL MOLECULE INHIBITORS OF EBOLA AND LASSA FEVER VIRUSES AND METHODS OF USE 
048 20210163506
 
BORON-CONTAINING COMPOUNDS 
049 20210163508
 
HIGHLY EFFICIENT FREE RADICAL PHOTOPOLYMERIZATIONS THROUGH ENABLED DARK CURE 
050 20210163532
 
NOVEL MACROCYCLIC OPIOID PEPTIDES 
051 20210163533
 
CELL PENETRATING PEPTIDE 
052 20210163551
 
DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS 
053 20210163555
 
TARGETING P18 FOR mTOR-RELATED DISORDERS 
054 20210163556
 
BDNF MIMETIC PEPTIDE AMPHIPHILES 
055 20210163557
 
METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER\'S DISEASE AND IMPROVING NORMAL MEMORY 
056 20210163570
 
ENGINEERED CELLS, T CELL IMMUNE MODULATING ANTIBODIES AND METHODS FOR USING THE SAME 
057 20210163578
 
HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY 
058 20210163602
 
PSGL-1 MODULATORS AND USES THEREOF 
059 20210163609
 
METHOD FOR TREATING AUTOIMMUNE DISEASE 
060 20210163624
 
T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR A WTI PEPTIDE PRESENTED BY HLA-A2 
061 20210163869
 
PRESSURE-DRIVEN, ADJUSTABLE THROUGHPUT FLUIDICS FOR TISSUE AND CELL PERIFUSIONS 
062 20210163872
 
Cell Reprogramming Therapy 
063 20210163888
 
INDUCTION OF MYELINATING OLIGODENDROCYTES IN HUMAN CORTICAL SPHEROIDS 
064 20210163892
 
GENERATING HPV ANTIGEN-SPECIFIC CELLS FROM A NAIVE T CELL POPULATION 
065 20210163900
 
NUCLEIC ACID MODIFICATION WITH TOOLS FROM OXYTRICHA 
066 20210163924
 
EVOLUTION OF BONT PEPTIDASES 
067 20210163940
 
COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES 
068 20210163944
 
NOVEL CAS12B ENZYMES AND SYSTEMS 
069 20210163948
 
RNA TARGETING OF MUTATIONS VIA SUPPESSOR tRNAs AND DEAMINASES 
070 20210163949
 
MODULATION OF ALTERNATIVE MDM2 SPLICING 
071 20210163954
 
METHODS OF TREATING VEGF/VEGFR RESISTANT PROSTATE CANCER USING COMBINATION THERAPY 
072 20210163964
 
ENGINEERED STREPTOMYCES ALBUS STRAINS 
073 20210163984
 
COMPOSITIONS FOR REDUCING SARCOLIPIN EXPRESSION AND PREVENTING AND TREATING MUSCULAR DYSTROPHY AND CARDIOMYOPATHY AND METHODS OF USE 
074 20210163988
 
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON 
075 20210163993
 
COMPOSITIONS AND METHODS FOR PRODUCTION OF PROTEINS 
076 20210164005
 
METHODS FOR INDUCING BIOORTHOGONAL REACTIVITY 
077 20210164011
 
BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME 
078 20210164026
 
STOICHIOMETRIC TUNING OF NUCLEIC ACID HYBRIDIZATION PROBES BY AUXILIARY OLIGONUCLEOTIDE SPECIES 
079 20210164054
 
BIOMARKERS FOR CANCER IMMUNOTHERAPY OUTCOMES 
080 20210164056
 
USE OF METASTASES-SPECIFIC SIGNATURES FOR TREATMENT OF CANCER 
081 20210164059
 
ON DEMAND, PORTABLE, CELL-FREE MOLECULAR SENSING PLATFORM 
082 20210164992
 
COMPOSITIONS AND METHODS RELATED TO INNATE RESPONSE TO DNA AND REGULATION OF INTERFERON-BETA 
083 20210164998
 
DISCRIMINATING PARKINSON\'S DISEASE FROM MULTIPLE SYSTEM ATROPHY USING ALPHA-SYNUCLEIN PMCA 
084 20210165065
 
Methods for Correcting Motion-Encoding Gradient Nonlinearities in Magnetic Resonance Elastography 
085 20210166433
 
DOMAIN MATCHING METHODS FOR TRANSPORTABLE IMAGING APPLICATIONS 
086 20210166782
 
CLINICAL INTERPRETATION OF GENOMIC AND TRANSCRIPTOMIC DATA AT THE POINT OF CARE FOR PRECISION CANCER MEDICINE 
087 20210166783
 
METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS 
088 20210166927
 
SAMPLE QUANTITATION USING A MINIATURE MASS SPECTROMETER 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20210161084
 
DISPOSABLE DIAPER RECYCLING AND APPLICATIONS THEREOF 
002 20210161383
 
CHROMATIC BIOLUMINESCENCE AS A CELLULAR LEVEL READOUT SYSTEM OF NEURAL ACTIVITY 
003 20210161388
 
METHOD, SYSTEM AND SPECULUM-FREE OPTICAL PROBE FOR OPTICAL ASSESSMENT OF CERVIX, AND APPLICATIONS OF SAME 
004 20210161395
 
NON-INVASIVE VENOUS WAVEFORM ANALYSIS FOR EVALUATING A SUBJECT 
005 20210161405
 
VITAL SIGNS MONITOR 
006 20210162014
 
ENCAPSULATION OF ULTRA-STABLE INSULIN ANALOGUES WITH POLYMER MELTS 
007 20210162373
 
Zinc(II) and Gallium(III) Catalysts for Olefin Reactions 
008 20210162504
 
THREE-DIMENSIONAL LASER-ASSISTED PRINTING OF STRUCTURES FROM NANOPARTICLES 
009 20210163297
 
DENDRITIC MATERIALS WITH HIERARCHICAL POROSITY 
010 20210163384
 
Compositions and Methods for Reducing Enones to Saturated Alcohols 
011 20210163386
 
METHODS AND COMPOSITIONS FOR THE CATALYTIC UPGRADING OF ALCOHOLS 
012 20210163424
 
ECO-FRIENDLY MATERIALS AND METHODS FOR RENEWABLE AND SUSTAINABLE APPLICATIONS IN MATERIAL CHEMISTRY 
013 20210163521
 
AMPHIPHILIC AMINOGLYCOSIDE CONNEXIN HEMICHANNEL INHIBITORS 
014 20210163558
 
FIBROUS PROTEINACEOUS NETWORKS AND METHODS OF USE THEREOF 
015 20210163676
 
OLEFIN METATHESIS PHOTOPOLYMERS 
016 20210163707
 
POLYELEMENTAL HETEROSTRUCTURE NANOPARTICLES AND METHODS OF MAKING THE SAME 
017 20210163759
 
Infrared Fluorescent Coatings 
018 20210163776
 
COATING COMPOSITIONS, PROCESSES, AND APPLICATIONS FOR LOW FRICTION AND HIGH DURABILITY SUBSTRATES 
019 20210163797
 
BODY FLUID RESISTANT TISSUE ADHESIVES 
020 20210163867
 
PERFUSION BIOREACTOR DRIVEN BY OSMOTIC PRESSURE GRADIENTS 
021 20210163940
 
COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES 
022 20210164005
 
METHODS FOR INDUCING BIOORTHOGONAL REACTIVITY 
023 20210164870
 
MICROFLUIDIC DEVICES FOR INVESTIGATING CRYSTALLIZATION 
024 20210164953
 
METHOD AND APPARATUS FOR ANALYZING STALK STRENGTH 
025 20210164955
 
MEASURING CONCENTRATION OF ANALYTES IN LIQUID SAMPLES USING SURFACE-ENHANCED RAMAN SPECTROSCOPY 
026 20210164971
 
DROPLET ARRAYS FOR DETECTION AND QUANTIFICATION OF ANALYTES 
027 20210165069
 
ULTRASONIC BEACON TRACKING 
028 20210166078
 
LEVERAGING SMART-PHONE CAMERAS AND IMAGE PROCESSING TECHNIQUES TO CLASSIFY MOSQUITO GENUS AND SPECIES 
029 20210166138
 
SYSTEMS AND METHODS FOR AUTOMATICALLY DETECTING AND REPAIRING SLOT ERRORS IN MACHINE LEARNING TRAINING DATA FOR A MACHINE LEARNING-BASED DIALOGUE SYSTEM 
030 20210166393
 
Pixel-wise Hand Segmentation of Multi-modal Hand Activity Video Dataset 
031 20210167394
 
PROTECTIVE LAYERS FOR BATTERY ELECTRODES 
032 20210167743
 
FAST AMPLITUDE DETECTOR AND AUTOMATIC GAIN CONTROL 
033 20210168063
 
Distributed, Packet-Mediated, Packet Routing 
034 20210168238
 
Methods and Systems for Detecting Disinformation and Blocking Robotic Calls 

Up to Start Of Table

Take Me To The Details

Department of Defense (DOD) Agencies

Patent Title
001 20210161900
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF SENESCENT TUMOR CELLS 
002 20210163403
 
COMPOSITIONS AND METHODS FOR TREATING CANCER 
003 20210163731
 
TRANSIENT POLYMER FORMULATIONS, ARTICLES THEREOF, AND METHODS OF MAKING AND USING SAME 
004 20210163947
 
ULTRASENSITIVE AND MULTIPLEXED CELL-FREE BIOSENSORS USING CASCADED AMPLIFICATION AND POSITIVE FEEDBACK 
005 20210163954
 
METHODS OF TREATING VEGF/VEGFR RESISTANT PROSTATE CANCER USING COMBINATION THERAPY 
006 20210163969
 
COMBINED TRANSCRIPTION AND TRANSLATION PLATFORM DERIVED FROM PLANT PLASTIDS AND METHODS FOR IN VITRO PROTEIN SYNTHESIS AND PROTOTYPING OF GENETIC EXPRESSION IN PLANTS 
007 20210164059
 
ON DEMAND, PORTABLE, CELL-FREE MOLECULAR SENSING PLATFORM 
008 20210164592
 
CONDUITS FOR TRANSPORTING FLUIDS AND METHODS OF FABRICATING THE SAME 
009 20210164930
 
METAL-ORGANIC FRAMEWORKS AS ION-TO-ELECTRON TRANSDUCERS AND DETECTORS 
010 20210165092
 
SYSTEM FOR SENSING BACKSCATTER TAG COMMUNICATIONS FROM RETRODIRECTIVE ANTENNA ARRAYS 
011 20210166107
 
EVENT-BASED NEURAL NETWORK WITH HIERARCHICAL ADDRESSING FOR ROUTING EVENT PACKETS BETWEEN CORE CIRCUITS OF THE NEURAL NETWORK 
012 20210167494
 
PROGRAMMABLE BEAMFORMING SYSTEM INCLUDING ELEMENT-LEVEL ANALOG CHANNELIZER 

Department of the ARMY (DOA)

Patent Title
001 20210161126
 
Devices and Methods to Improve and Assess Viability of Human Livers 
002 20210161890
 
COMPOSITIONS AND METHODS FOR TREATING BRAIN DYSFUNCTION 
003 20210161900
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF SENESCENT TUMOR CELLS 
004 20210162002
 
REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS 
005 20210162076
 
Aptamer Compositions and Methods of Use Thereof 
006 20210163403
 
COMPOSITIONS AND METHODS FOR TREATING CANCER 
007 20210163424
 
ECO-FRIENDLY MATERIALS AND METHODS FOR RENEWABLE AND SUSTAINABLE APPLICATIONS IN MATERIAL CHEMISTRY 
008 20210163532
 
NOVEL MACROCYCLIC OPIOID PEPTIDES 
009 20210163797
 
BODY FLUID RESISTANT TISSUE ADHESIVES 
010 20210163938
 
MRNA Driven Expression of RNA Editors for Treatment of Pathologies 
011 20210163954
 
METHODS OF TREATING VEGF/VEGFR RESISTANT PROSTATE CANCER USING COMBINATION THERAPY 
012 20210164930
 
METAL-ORGANIC FRAMEWORKS AS ION-TO-ELECTRON TRANSDUCERS AND DETECTORS 
013 20210167244
 
METHODS OF FABRICATING PLANAR INFRARED PHOTODETECTORS 
014 20210167390
 
DRY MILLING ADDITIVE AND PROCESS 

Department of the Navy (DON) | United States Marine Corps (USMC)

Patent Title
001 20210161850
 
USE OF KETONE ESTERS FOR PREVENTION OF CNS OXYGEN TOXICITY 
002 20210162709
 
ORGANICALLY MODIFIED CHALCOGENIDE POLYMERS FOR USE AS OPTICAL ADHESIVE MATERIALS 
003 20210163298
 
NANODIAMOND REDUCTION PHOTOCHEMISTRY 
004 20210163539
 
Wet Adhesive Peptides 
005 20210163797
 
BODY FLUID RESISTANT TISSUE ADHESIVES 
006 20210165852
 
COMPUTER-IMPLEMENTED PERCEPTUAL APPARATUS 

Department of the Air Force (DAF)| United States Space Force (USSF)

Patent Title
001 20210163370
 
DOPED MATERIALS/ALLOYS AND HOT ISOSTATIC PRESSING METHOD OF MAKING SAME 
002 20210163947
 
ULTRASENSITIVE AND MULTIPLEXED CELL-FREE BIOSENSORS USING CASCADED AMPLIFICATION AND POSITIVE FEEDBACK 
003 20210164059
 
ON DEMAND, PORTABLE, CELL-FREE MOLECULAR SENSING PLATFORM 
004 20210164841
 
Systems and Methods for High-Speed, Spectroscopic, Gas-Phase Thermometry 
005 20210166583
 
SYSTEM AND METHOD FOR THREE-DIMENSIONAL AUGMENTED REALITY GUIDANCE FOR USE OF EQUIPMENT 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20210162371
 
FUNCTIONALIZED POROUS ORGANIC POLYMERS AS URANIUM NANO-TRAPS FOR EFFICIENT URANIUM EXTRACTION 
002 20210163377
 
CATALYTIC SYNTHESIS OF SUPER LINEAR ALKENYL ARENES USING RHODIUM CATALYSTS 
003 20210163759
 
Infrared Fluorescent Coatings 
004 20210163770
 
THIN FILMS PRINTED WITH CHALCOGENIDE GLASS INKS 
005 20210163917
 
ENZYME FORMULATION AND METHOD FOR DEGRADATION 
006 20210163966
 
PRODUCTION OF ORGANIC ACIDS FROM ASPERGILLUS CIS-ACONITIC ACID DECARBOXYLASE (CADA) DELETION STRAINS 
007 20210164116
 
REACTOR WITH ADVANCED ARCHITECTURE FOR THE ELECTROCHEMICAL REACTION OF CO2, CO AND OTHER CHEMICAL COMPOUNDS 
008 20210164118
 
NOVEL MULTI-METAL CATALYSTS AND DEVICES AND METHODS OF USE THEREOF 
009 20210164695
 
FALLING PARTICLE RECEIVER SYSTEMS WITH MASS FLOW CONTROL 
010 20210164697
 
Multi-Stage Falling Particle Receivers 
011 20210164923
 
METHODS OF PREPARING SINGLE-WALLED CARBON NANOTUBE NETWORKS 
012 20210165381
 
SYSTEM ARCHITECTURE AND METHOD OF PROCESSING DATA THEREIN 
013 20210165606
 
APPARATUS AND METHODS FOR MANAGING PACKET TRANSFER ACROSS A MEMORY FABRIC PHYSICAL LAYER INTERFACE 
014 20210165984
 
Polarization-based coding/encryption using organic charge-transfer materials 
015 20210167394
 
PROTECTIVE LAYERS FOR BATTERY ELECTRODES 
016 20210167395
 
POROUS METAL-ION AFFINITY MATERIAL 
017 20210167427
 
METHOD AND SYSTEM TO SEPARATE OPTICALLY MEASURED COUPLED PARAMETERS 
018 20210167429
 
PHOTO-ASSISTED FAST CHARGING OF LITHIUM MANGANESE OXIDE SPINEL (LiMn2O4) IN LITHIUM-ION BATTERIES 
019 20210167462
 
Sodium Electrochemical Interfaces with NaSICON-Type Ceramics 

Up to Start Of Table

Emerging Technology

Emerging Climate Change Technologies

Patents containing 'Y" CPC symbols indicate emerging technologies important to US scientific leadership.

Patent documents that contain a Y02 or Y04 CPC symbol are already classified elsewhere. USPTO add the Y symbols to the classification data is to monitor new technological development covering clean technology and inventions impacting climate change, important American science and technology interests.

Y02 — Green House Gas Mitigation — Y02 covers selected technologies, which control, reduce or prevent anthropogenic emissions of greenhouse gases (GHG), in the framework of the Kyoto Protocol and the Paris Agreement, and technologies that allow adapting to the adverse effects of climate change. Y02A covers technologies for adaptation to climate change, — technologies that allow adapting to the adverse effects of climate change in human, industrial (including agriculture and livestock), and economic activities. Y02P covers climate change mitigation technologies in any kind of industrial processing or production activity, including the agroalimentary industry (relating to agriculture and food), agriculture, fishing, ranching, and the like.

Y04 — Enabling Technologies — Y04 is focused on the information and communications inventions that facilitate climate change technology. Y04S covers systems integrating technologies related to power network operation, communication or information technologies for improving electrical power generation, transmission, distribution, management, or usage. Examples of the art covered here are technologies related to smart grids, home appliances, and systems supporting the interoperability of electric or hybrid vehicles.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent application you are interested appears at the top of the list on the details page.
Class
Y02A Technologies for Adaptation to Climate Change
20210162053  NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS      
Y02W Climate Change Mitigation Technologies Related to Wastewater Treatment or Waste Management
20210161084  DISPOSABLE DIAPER RECYCLING AND APPLICATIONS THEREOF      

Count of patent applications funded by The Department of Health and Human Services (HHS).

Department | Agency This Week
Department of Health and Human Services (HHS)88
National Institutes of Health (NIH)77
National Cancer Institute (NCI)28
National Institute of General Medical Sciences (NIGMS)15
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12
National Institute of Neurological Disorders and Stroke (NINDS)9
National Institute of Allergy and Infectious Diseases (NIAID)8
National Heart, Lung, and Blood Institute (NHLBI)7
National Institute of Biomedical Imaging and Bioengineering (NIBIB)6
National Institute on Aging (NIA)5
National Institute on Drug Abuse (NIDA)5
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)3
National Institute of Mental Health (NIMH)3
National Institute of Child Health and Human Development (NICHD)2
National Institute of Dental and Craniofacial Research (NIDCR)2
National Center for Advancing Translational Sciences (NCATS)1
National Eye Institute (NEI)1
National Human Genome Research Institute (NHGRI)1
National Institute of Environmental Health Sciences (NIEHS)1
Office of the Director (NIHOD)1
U.S. Public Health Service (USPHS)1

Up to Start Of Table

Higher Education Research and Development (HERD)

FedInvent follows the HERD the Higher Education Research and Development institutions — the colleges and universities; research institutions, and medical schools that benefit from federal funding and rely on it to make important discoveries that drive American innovation. Taxpayer funded patents coming from mostly American and sometime foreign universities are an important indicia of the vitality of the American innovation ecosphere.

MEMBERS OF THE HERD

The National Science Foundation (NSF) Higher Education Research and Development (HERD) Survey is the primary source of information on R&D expenditures at 916 US colleges and universities that expended at least $150,000 in separately accounted for R&D in the fiscal year. We use the NSF list to keep track of which colleges and universities are receiving taxpayer-funded patents and filing patent applications.

WATCH This SPACE

We're working on our data analytics and will be reporting taxpayer-funded patents and patent applications shortly. In the meantime, FedInvent will post interesting information about the HERD Innovation Ecosphere here.

Top Ten Universities By R&D Expenditures
  1. Johns Hopkins University
  2. University of Michigan
  3. University of Washington
  4. University of California, San Diego
  5. University of California, San Francisco
  6. Columbia University in the City of New York
  7. Stanford University
  8. University Pittsburgh
  9. University Pennsylvania
  10. Duke University

Patent Applications by Scientific Domain.

This section contains the number of patents organiized by high level scientific and technical domain. The data is arranged by the first Cooperative Patent Classification System (CPC) patent symbol assigned to the patent. This indicates the scope and nature of the patented invention for a patent or a patent application.

Global patent offices use patent classification as their lingua franca — the common language — for exchanging information about inventions and what scientific and technical art a patent contains. The classifications assigned to a patent are used by patent examiners to find prior art and to determine if a particular patent's claims are novel. Patent classifications are also used for global enforcement of patent rights, treaties, and agreements.

Class Class Definition First
(Original)
Inventive
(CrossRef)
CPC A61 Medical or Veterinary Science; Hygiene 47 317
CPC C12 Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or Genetic Engineering 29 201
CPC C07 Organic Chemistry 27 158
CPC G01 Measuring; Testing 13 45
CPC G06 Computing; Calculating; Counting 10 47
CPC B01 Physical or Chemical Processes or Apparatus in General 3 54
CPC H01 Basic Electric Elements 9 43
CPC C08 Organic Macromolecular Compounds; Their Preparation or Chemical Working-up; Compositions Based Thereon 3 33
CPC C09 Dyes; Paints; Polishes; Natural Resins; Adhesives; Compositions Not Otherwise Provided For; Applications of Materials Not Otherwise Provided for 5 20
CPC G16 Information and Communication Technology [ICT] Specially Adapted for Specific Application Fields 2 18
CPC B32 Layered Products 1 17
CPC H04 Electric Communication Technique 2 13
CPC C25 Electrolytic or Electrophoretic Processes; Apparatus Therefor 2 11
CPC C01 Inorganic Chemistry 2 9
CPC A01 Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing 3 5
CPC Y02 Technologies or Applications for Mitigation or Adaptation Against Climate Change 0 8
CPC F24 Heating; Ranges; Ventilating 2 5
CPC C04 Cements; Concrete; Artificial Stone; Ceramics; Refractories 1 5
CPC G05 Controlling; Regulating 2 3
CPC F16 Engineering Elements and Units; General Measures for Producing and Maintaining Effective Functioning of Machines or Installations; Thermal Insulation in General 1 4
CPC B64 Aircraft; Aviation; Cosmonautics 1 3
CPC B22 Casting; Powder Metallurgy 1 2
CPC F15 Fluid-pressure Actuators; Hydraulics or Pneumatics in General 1 1
CPC G09 Education; Cryptography; Display; Advertising; Seals 1 1
CPC H03 Basic Electronic Circuitry 1 1

Up to Start Of Table

Count of Inventors by Country and U.S. State

Patent Applications by country and state based on location information of first named inventors and all listed inventors.

Country First Named Inventors All Inventors
United States of America 162 552
Switzerland 2 3
Japan 1 8
Austria 1 3
New Zealand 1 2
South Korea 1 1
Russian Federation 1 1
China PRC 0 8
Germany 0 4
United Kingdom 0 4
Australia 0 2
Canada 0 1
France 0 1
Singapore 0 1
Taiwan 0 1
U.S. State First Named Inventors All Inventors
California 25 90
Massachusetts 21 77
Illinois 11 28
New York 10 24
Ohio 8 25
Virginia 7 28
Maryland 7 26
Florida 7 21
Texas 7 21
Pennsylvania 6 18
Indiana 6 16
New Jersey 5 11
Washington 5 10
Georgia 4 10
New Mexico 4 9
Idaho 3 12
Connecticut 3 8
New Hampshire 3 7
Tennessee 2 13
Colorado 2 10
Michigan 2 10
Minnesota 2 10
North Carolina 2 9
Wisconsin 2 7
Rhode Island 1 12
North Dakota 1 9
Arkansas 1 6
District of Columbia 1 6
Arizona 1 3
Missouri 1 3
Kansas 1 2
Nebraska 1 2
Delaware 0 5
Utah 0 2
Hawaii 0 1
Vermont 0 1

Up to Start Of Table

Count of Assignees and Applicants by Country and U.S. State

Patent Applications by country and state based on location information of Assignees and Applicants.

Country Assignees Applicants
United States of America 49199
Japan 34
United Kingdom 12
Canada 11
South Korea 11
China PRC 10
Australia 01
Austria 01
France 01
Netherlands 01
U.S. State Assignees Applicants
Massachusetts 831
California 627
New York 414
Virginia 47
Maryland 38
Indiana 37
Texas 37
Illinois 211
Florida 27
New Jersey 25
Georgia 24
District of Columbia 23
Pennsylvania 18
New Hampshire 17
Delaware 15
Washington 14
Wisconsin 12
Arizona 11
Arkansas 11
Missouri 11
Ohio 09
New Mexico 04
North Carolina 04
Connecticut 03
Idaho 03
Minnesota 03
Colorado 02
Michigan 02
Tennessee 02
Kansas 01
Nebraska 01
North Dakota 01
Rhode Island 01

Up to Start Of Table

Technology Center Explainer

How Tech Centers and Art Units Are Organized And Why It Matters

Patents travel from Technology Center to Art Unit to Group Art Unit to Patent Examiner.

The USPTO's patent corps is organized into Technology Centers (TCs), groups of patent examiners with specific scientific and technical domain expertise. Technology Centers are further divided into Art Units (AUs) organized by major types of inventive art within a scientific or technical domain. Art Units are organized into Group Art Units, even more specialized and granular teams of examiners.

Group Art Units (GAUs) are where patent examiners prosecute patent applications. Patent applications are docketed to examiners based on of specific subject matter classifications of a particular GAU.

Understanding Technology Centers, Art Units and Group Art Units helps you understand what type of inventions are being prosecuted within each scientific and technical domain, how long it takes from the date a patent application is filed to the time a final decision on the patentability of the invention is made.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1610 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
1620 Organic Chemistry
1630 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
1640 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
1650 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
1660 Plants

About Plant Patents

Plant Patents are granted by the Government to an inventor who has invented or discovered and asexually reproduced a distinct and new variety of plant, other than a tuber propagated plant or a plant found in an uncultivated state. If you've ever eaten a pluot, you've enjoyed the fruit of a plant patent.

Plant patent numbers begin with a "PP" followed by a five digit number. The first Plant Patent was issued in 1931. Plant patents are valid for 20 years from the filing date.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1710 Coating, Etching, Cleaning, Single Crystal Growth
1720 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
1730 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
1740 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
1760 Organic Chemistry, Polymers, Compositions
1770 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
1780 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
1790 Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry

Patents examined here cover:

Art Unit Technical & Scientific Domains
2110 Coating, Etching, Cleaning, Single Crystal Growth
2120 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
2130 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
2140/2170 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
2150/2160 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
2180 Organic Chemistry, Polymers, Compositions
2190 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus

Patents examined here cover:

Art Unit Technical & Scientific Domains
2410/2460/2470 Multiplex, VoIP
2420 Cable and Television
2430/2490 Cryptography and Security
2440/2450 Computer Networks
2480 Recording and Compression

Patents examined here cover:

Art Unit Technical & Scientific Domains
2610 Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
2620 Selective Visual Display Systems
2630 Digital and Optical Communications
2640 Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
2650 Videophones and Telephonic Communications; Audio Signals; Digital Audio Data Processing; Linguistics, Speech Processing and Audio Compression
2660 Digital Cameras; Image Analysis; Applications; pattern Recognition; Color and Compression; Enhancement and Transformation
2670 Facsimile; Printer; Color; halftone; Scanner; Computer Graphic Processing; 3-D Animation; Display Color; Attributes; Object Processing; Hardware and Memory
2680 Telemetry and Code Generation; Vehicles and System Alarms; Selective Communication; Dynamic Storage Systems; Mechanical parts of Disk Drives; Signal Processing and Control Processing in Disk Drives
2690 Selective Visual Display Systems

More broadly TC 2800 Art Units cover Semiconductors/Memory, Circuits/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing.

Patents examined here cover:

Art Unit Technical & Scientific Domains
2810/2820/2890 Semiconductors/Memory
2830/2840 Electrical Circuits and Systems
2850/2860 Printing/Measuring and Testing
2870/2880 Optics

About Design Patents

The design FOR an article. Not to the design OF an article.

Patents examined here cover Design patents cover the appearance of an article. The design for an article consists of the visual characteristics embodied in or applied to an article. Since a design is manifested in appearance, the subject matter of a design patent application may relate to the configuration or shape of an article, to the surface ornamentation applied to an article, to the combination of configuration and surface ornamentation.

Design is inseparable from the article to which it is applied and cannot exist alone merely as a scheme of surface ornamentation. It must be a definite, preconceived thing, capable of reproduction and not merely the chance result of a method.

Design patent numbers begin with a "D" followed by a six-digit number. The first Design Patent was issued in 1843. The term of a design patent is 15 years measured from the date of grant if the design application was filed on or after May 13, 2015 (or 14 years if filed before May 13, 2015).

Patents examined here cover:

Art Unit Technical & Scientific Domains
3610 Surface Transportation
3620 Business Methods — Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/Price, Reservations, Shipping and Transportation; Business Processing
3630 Static Structures, Supports and Furniture
3640 Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
3650 Material and Article Handling
3660 Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
3670 Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
3680 Business Methods — Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
3690 Business Methods — Finance/Banking/ Insurance

Patents examined here cover:

Art Unit Technical & Scientific Domains
3710 Amusement and Education Devices
3720 Manufacturing Devices and Processes, Machine Tools and Hand Tools
3730 Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
3740 Thermal and Combustion Technology, Motive and Fluid Power Systems
3750 Fluid Handling and Dispensing
3760 Refrigeration, Vaporization, Ventilation, and Combustion
3770 Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
3780 Body Treatment, Kinestherapy, and Exercising

FedInvent Patents

Each week FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding from the US federal government. We assemble a weekly patent catalog and analyze the inventions, the inventors, and the entities who received the patents. We map the patents back to the agency that funded the R&D that led to the new invention. FedInvent uses the funding opportunity descriptions, the grants, and the contracts that define the research areas of interest ,and the R&D policies and priorities of that drove and are driving the funding to organize each week's patents.

ABOUT OUR DATA

The weekly patent catalog includes patents with government interest statements indicating federal funding; and patents where the assignee, the owner of the invention, is the federal government. This includes work on federal grants, work on federal contracts, innovation by Federal Research and Development Centers (FFRDCs) funded by Federal Departments, and University Affiliated Research Centers funded by DoD.

Not every inventor is a government contractor. There are many inventions conceived and patented by scientists and engineers working for the federal government or serving in the military.

THE NUMBERS MAY NOT MATCH THE NUMBER OF PATENTS WE ANALYZE EACH WEEK

The numbers in the tables presented on this page will not add up to the number of patents granted each week because patents are counted by each agency that funded the creation of the invention. Patents and funding have a many-to-many relationship. One patent may have more than one funding grant or contract associated with it. A grant or contract may lead to more than one patent. More than one agency may have funded the inventors or the contract. More than one university or business may have worked together on an invention. When we report the numbers here, we associate a patent with all of the entities and funding that are reflected on the patent and report them to you. This approach presents a more complete picture of what's going on in the federal innovation ecosphere. Put another way, the numbers in the tables presented on this page may not always add up to the number of patents each week because patents are counted by each agency that funded the creation of the invention.

Subscribe to The FedInvent Newsletter

 The latest from FedInvent delivered right to your inbox Tuesdays & Thursdays.